ArticleJAMIA open2026
Development of a benchmarking dataset for symptom detection using large language models.
Article in JAMIA open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To develop a pipeline for evaluating large language models (LLMs) on the task of capturing symptoms from clinical encounters. Materials and Methods: We created a gold standard dataset of symptom annotations from simulated doctor-patient encounter excerpts (264 encounters; 16 symptoms; double-coded and adjudicated). Nine different LLMs from 4 vendors (OpenAI, Meta, DeepSeek, Moonshot AI) were used as examples to test our evaluation pipeline; outputs were assessed for correct structure and symptom information. Results: Of 3085 excerpts, 2087 (68%) contained symptoms. Pain, cough, and shortness of breath were most common; LLMs achieved F1 scores ranging 0.66-0.88 for these symptoms with minimal prompt engineering. Of tested models, GPT-4.1 demonstrated the best overall performance. Discussion: Our evaluation pipeline and benchmarking dataset are publicly available and applicable to various LLMs, including open-source models. Conclusion: This work supports the development and optimization of models that seek to improve patient symptom understanding.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.